Myricetin, a naturally occurring flavonol, ameliorates insulin resistance induced by a high-fructose diet in rats

Life Sciences

Volumn 81, Issue 21-22, 2007, Pages 1479-1488

  Liu, I Min ^a   Tzeng, Thing Fong ^b   Liou, Shorong Shii ^a   Lan, Ting Wei ^a  

^a TAJEN UNIVERSITY   (Taiwan)

^b Pao Chien Hospital   (Taiwan)

Author keywords

Fructose; Insulin resistance; Myricetin; Oral glucose tolerance test

Indexed keywords

FLAVONOL; FRUCTOSE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MYRICETIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P85; PROTEIN SUBUNIT; ROSIGLITAZONE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PROTEIN EXPRESSION; RAT; SOLEUS MUSCLE; SUGAR INTAKE; TRIACYLGLYCEROL BLOOD LEVEL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; CHOLESTEROL; DIET; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLAVONOIDS; FLAVONOLS; FRUCTOSE; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN; HEPATOCYTES; HYPOGLYCEMIC AGENTS; IMMUNOPRECIPITATION; INSULIN; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; PHOSPHORYLATION; RATS; RATS, WISTAR; RECEPTOR, INSULIN; THIAZOLIDINEDIONES; TRIGLYCERIDES;

ANIMALIA; RATTUS;

EID: 36048945645     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.08.045     Document Type: Article

References (36)

1. Agius L., Peak M., Newgard C.B., Gomez-Foix A.M., and Guinovart J.J. Evidence for a role of glucose-induced translocation of glucokinase in the control of hepatic glycogen synthesis. The Journal of Biological Chemistry 271 48 (1996) 30479-30486
2. Basciano H., Federico L., and Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutrition and Metabolism 2 1 (2005) 5
3. Carvalho E., Rondinone C., and Smith U. Insulin resistance in fat cells from obese Zucker rats-evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4. Molecular and Cellular Biochemistry 206 1-2 (2000) 7-16
4. Dajas F., Rivera F., Blasina F., Arredondo F., Echeverry C., Lafon L., Morquio A., and Heizen H. Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotoxicity Research 5 6 (2003) 425-432
5. Gervois P., Fruchart J.C., and Staels B. Drug insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors. Nature Clinical Practice Endocrinology and Metabolism 3 2 (2007) 145-156
6. Granberry M.C., Hawkins J.B., and Franks A.M. Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure. American Journal of Health-System Pharmacy 64 9 (2007) 931-936
7. Griffiths L.A., and Smith G.E. Metabolism of myricetin and related compounds in the rat. Metabolite formation in vivo and by the intestinal microflora in vitro. Biochemical Journal 130 1 (1972) 141-151
8. Grundy S.M. Metabolic syndrome: a multiplex cardiovascular risk factor. Journal of Clinical Endocrinology and Metabolism 92 2 (2007) 399-404
9. Harnly J.M., Doherty R.F., Beecher G.R., Holden J.M., Haytowitz D.B., Bhagwat S., and Gebhardt S. Flavonoid content of U.S. fruits, vegetables, and nuts. Journal of Agricultural and Food Chemistry 54 26 (2006) 9966-9977
10. Hu G., Rico-Sanz J., Lakka T.A., and Tuomilehto J. Exercise, genetics and prevention of type 2 diabetes. Essays in Biochemistry 42 (2006) 177-192
11. Hyakukoku M., Higashiura K., Ura N., Murakami H., Yamaguchi K., Wang L., Furuhashi M., Togashi N., and Shimamoto K. Tissue-specific impairment of insulin signaling in vasculature and skeletal muscle of fructose-fed rats. Hypertension Research 26 2 (2003) 169-176
12. Ishiki M., and Klip A. Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners. Endocrinology 146 12 (2005) 5071-5078
13. Ko C.H., Shen S.C., Lee T.J., and Chen Y.C. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Molecular Cancer Therapeutics 4 2 (2005) 281-290
14. Landolfi R., Mower R.L., and Steiner M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Biochemical Pharmacology 33 9 (1984) 1525-1530
15. Le K.A., and Tappy L. Metabolic effects of fructose. Current Opinion in Clinical Nutrition and Metabolic Care 9 4 (2006) 469-475
16. Li X., Hansen P.A., Xi L., Chandraratna R.A., Burant C.F., Li X., Hansen P.A., Xi L., Chandraratna R.A., and Burant C.F. Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors. The Journal of Biological Chemistry 280 46 (2005) 38317-38327
17. Liu I.M., Liou S.S., Lan T.W., Hsu F.L., and Cheng J.T. Myricetin as the active principle of Abelmoschus moschatus to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Medica 71 1 (2005) 617-621
18. Liu I.M., Liou S.S., Lan T.W., Hsu F.L., and Cheng J.T. Mediation of β-endorphin by myricetin to lower plasma glucose in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology 104 1-2 (2006) 199-206
19. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 9 (1999) 1462-1470
20. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 7 (1985) 412-419
21. Miean K.H., and Mohamed S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. Journal of Agricultural and Food Chemistry 49 6 (2001) 3106-3112
22. Mira L., Fernandez M.T., Santos M., Rocha R., Florencio M.H., and Jennings K.R. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radical Research 36 11 (2002) 1199-1208
23. Ong K.C., and Khoo H.E. Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transport translocation. Biochemical Pharmacology 51 4 (1996) 423-429
24. Ong K.C., and Khoo H.E. Biological effects of myricetin. General Pharmacology 29 2 (1997) 121-126
25. Ong K.C., and Khoo H.E. Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life Sciences 67 14 (2000) 1695-1705
26. Ono K., Nakane H., Fukushima M., Chermann J.C., and Barre Sinoussi F. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. European Journal of Biochemistry 190 3 (1990) 469-476
27. Pearson S.L., Cawthorne M.A., Clapham J.C., Dunmore S.J., Holmes S.D., Moore G.B., Smith S.A., and Tadayon M. The thiazolidinedione insulin sensitizer, BRL 49653, increases the expression of PPARg and aP2 in adipose tissue of high fat-fed rats. Biochemical and Biophysical Research Communications 229 3 (1996) 752-757
28. Robak J., and Gryglewski R.J. Flavonoids are scavengers of superoxide anions. Biochemical Pharmacology 37 5 (1988) 837-841
29. Robak J., Shridi F., Wolbis M., and Krolikowska M. Screening of the influence of flavonoids on lipoxygenase and cyclooxygenase activity, as well as on nonenzymic lipid oxidation. Polish Journal of Pharmacology and Pharmacy 40 5 (1988) 451-458
30. Rodriguez E., Pulido N., Romero R., Arrieta F., Panadero A., and Rovira A. Phosphatidylinositol 3-kinase activation is required for sulfonylurea stimulation of glucose transport in rat skeletal muscle. Endocrinology 145 2 (2004) 679-685
31. Schwartz S.L. Diabetes and dyslipidaemia. Diabetes, Obesity & Metabolism 8 4 (2006) 355-364
32. Shulman G.I. Cellular mechanisms of insulin resistance. Journal of Clinical Investigation 106 2 (2000) 171-176
33. Song X.M., Ryder J.W., Kawano Y., Chibalin A.V., Krook A., and Zierath J.R. Muscle fiber type specificity in insulin signal transduction. American Journal of Physiology 277 6 Pt 2 (1999) R1690-R1696
34. Su C.F., Chang Y.Y., Pai H.H., Liu I.M., Lo C.Y., and Cheng J.T. Infusion of beta-endorphin improves insulin resistance in fructose-fed rats. Hormone and Metabolic Research 36 8 (2004) 571-577
35. Tzeng S.H., Ko W.C., Ko F.N., and Teng C.M. Inhibition of platelet aggregation by some flavonoids. Thrombosis Research 64 1 (1991) 91-100
36. Ye J.M., Dzamko N., Hoy A.J., Iglesias M.A., Kemp B., and Kraegen E. Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats. Diabetes 55 10 (2006) 2797-2804